171 related articles for article (PubMed ID: 33333694)
1. [Clinical characteristics and prognosis in 84 patients with angioimmunoblastic T-cell lymphoma: a single-center analysis].
Li TT; Luo LT; Chen Y; Yang T; Hu JD
Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):915-920. PubMed ID: 33333694
[No Abstract] [Full Text] [Related]
2. Clinical characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as an independent prognostic factor.
Li Y; Yang C; Mao L; Wang J; Li C; Qian W
Medicine (Baltimore); 2017 Sep; 96(39):e8091. PubMed ID: 28953629
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma.
Lee YP; Yoon SE; Cho J; Ko YH; Jo H; Kim SJ; Kim WS
Ann Hematol; 2022 Jul; 101(7):1535-1543. PubMed ID: 35639152
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan.
Tokunaga T; Shimada K; Yamamoto K; Chihara D; Ichihashi T; Oshima R; Tanimoto M; Iwasaki T; Isoda A; Sakai A; Kobayashi H; Kitamura K; Matsue K; Taniwaki M; Tamashima S; Saburi Y; Masunari T; Naoe T; Nakamura S; Kinoshita T
Blood; 2012 Mar; 119(12):2837-43. PubMed ID: 22308294
[TBL] [Abstract][Full Text] [Related]
5. A novel prognostic model for angioimmunoblastic T-cell lymphoma: A retrospective study of 55 cases.
Sun J; He S; Cen H; Zhou D; Li Z; Wang MY; Ke Q; Guo BP; Liao CC; Rong C; Zhong DN; Tan XH
J Int Med Res; 2021 May; 49(5):3000605211013274. PubMed ID: 34034561
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project.
Advani RH; Skrypets T; Civallero M; Spinner MA; Manni M; Kim WS; Shustov AR; Horwitz SM; Hitz F; Cabrera ME; Dlouhy I; Vassallo J; Pileri SA; Inghirami G; Montoto S; Vitolo U; Radford J; Vose JM; Federico M
Blood; 2021 Jul; 138(3):213-220. PubMed ID: 34292324
[TBL] [Abstract][Full Text] [Related]
7. Clinical features, outcome and prognostic factors of 87 patients with angioimmunoblastic T cell lymphoma in Taiwan.
Kao HW; Lin TL; Shih LY; Dunn P; Kuo MC; Hung YS; Wu JH; Tang TC; Chang H; Kuo TT; Ou CW; Wang PN
Int J Hematol; 2016 Aug; 104(2):256-65. PubMed ID: 27095042
[TBL] [Abstract][Full Text] [Related]
8. Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma.
Shiratori S; Kosugi-Kanaya M; Shigematsu A; Kobayashi H; Yamamoto S; Kobayashi N; Iwasaki H; Mori A; Kunieda Y; Yutaka T; Kurosawa M; Kakinoki Y; Endo T; Kondo T; Hashino S; Teshima T;
Leuk Lymphoma; 2015; 56(9):2592-7. PubMed ID: 25563559
[TBL] [Abstract][Full Text] [Related]
9. Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy.
Chihara D; Oki Y; Ine S; Yamamoto K; Kato H; Taji H; Kagami Y; Yatabe Y; Nakamura S; Morishima Y
Leuk Lymphoma; 2009 Dec; 50(12):1999-2004. PubMed ID: 19860627
[TBL] [Abstract][Full Text] [Related]
10. Development of a Novel Clinical Prognostic Model for Patients With Angioimmunoblastic T-Cell Lymphoma.
Huang C; Zhang H; Gao Y; Diao L; Liu L
Technol Cancer Res Treat; 2020; 19():1533033820964231. PubMed ID: 33073702
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic characteristics, outcomes, and prognostic factors of angioimmunoblastic T-cell lymphoma in China.
Wei C; Li W; Qin L; Liu S; Xue C; Ren K; Zhang Z; Liu C; Bao F; Zhang H; Zhou H; Li Z; Wu H; Zou L; Liu L; Jing H; Zhang W
Cancer Med; 2023 Feb; 12(4):3987-3998. PubMed ID: 36106610
[TBL] [Abstract][Full Text] [Related]
12. Analysis of clinical characteristics and prognostic factors for angioimmunoblastic T-cell lymphoma.
Kameoka Y; Takahashi N; Itou S; Kume M; Noji H; Kato Y; Ichikawa Y; Sasaki O; Motegi M; Ishiguro A; Tagawa H; Ishizawa K; Ishida Y; Ichinohasama R; Harigae H; Sawada K
Int J Hematol; 2015 Jun; 101(6):536-42. PubMed ID: 25739382
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of lymphocyte-to-monocyte ratio in angioimmunoblastic T cell lymphoma].
Niu JY; Zhu HY; Wang L; Fan L; Liang JH; Cao L; Wu W; Xia Y; Wu JZ; Li JY; Xu W
Zhonghua Xue Ye Xue Za Zhi; 2018 Apr; 39(4):265-270. PubMed ID: 29779318
[No Abstract] [Full Text] [Related]
14. Angioimmunoblastic T-cell lymphoma: treatment strategies and prognostic factors from a retrospective multicenter study in China.
Zhang C; Mi L; Wu M; Liu W; Ma H; Ren J; Zhao L; Wang X; Song Y; Zhu J
Leuk Lymphoma; 2022 May; 63(5):1152-1159. PubMed ID: 34957894
[TBL] [Abstract][Full Text] [Related]
15. Elevated absolute monocyte count predicts unfavorable outcomes in patients with angioimmunoblastic T-cell lymphoma.
Yang YQ; Liang JH; Wu JZ; Wang L; Qu XY; Cao L; Zhao XL; Huang DP; Fan L; Li JY; Xu W
Leuk Res; 2016 Mar; 42():88-92. PubMed ID: 26764222
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic significance of NCCN-International Prognostic Index (NCCN-IPI) for patients with peripheral T-cell lymphoma treated with CHOP-based chemotherapy].
Zhang MC; Xu PP; Zhong HJ; Zhao X; Zhao WL; Cheng S
Zhonghua Xue Ye Xue Za Zhi; 2017 Sep; 38(9):772-777. PubMed ID: 29081194
[No Abstract] [Full Text] [Related]
17. The derived neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with angioimmunoblastic T-cell lymphoma.
Hong H; Fang X; Huang H; Wang Z; Lin T; Yao H
Br J Haematol; 2020 Jun; 189(5):908-912. PubMed ID: 32103494
[TBL] [Abstract][Full Text] [Related]
18. [Study of prognostic related factors of elderly patients with T/NK cell lymphoma].
Wang Y; Qian Y; Wu LL; Zhao BB; Xu PP; Zhao WL; Wang L
Zhonghua Xue Ye Xue Za Zhi; 2013 Jan; 34(1):12-5. PubMed ID: 23597457
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and prognostic factors of angioimmunoblastic T-cell lymphoma in Taiwan: a single-institution experience.
Lin HN; Liu CY; Hong YC; Pai JT; Yang CF; Yu YB; Hsiao LT; Chiou TJ; Liu JH; Gau JP; Tzeng CH; Chen PM
Leuk Lymphoma; 2010 Dec; 51(12):2208-14. PubMed ID: 21054150
[TBL] [Abstract][Full Text] [Related]
20. [Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].
Liu P; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Yang JL; Yang S; Wen TY; Shi YK
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):234-241. PubMed ID: 32252203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
